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Summary: The effect of pH on the unfolding pathway and the stability of the toxic protein 
abrin-II have been studied by increasing denaturant concentrations of guanidine hydrochloride 
and by monitoring the change in 8,1-anilino naphthalene sulfonic acid (ANS) fluorescence upon 
binding to the hydrophobic sites of the protein. Intrinsic protein fluorescence, far and near UV- 
circular dichroism (CD) spectroscopy and ANS binding studies reveal that the unfolding of 
abrin-II occurs through two intermediates at pH 7.2 and one intermediate at pH 4.5. At pH 7.2, 
the two subunits A and B of abrin-II unfold sequentially. The native protein is more stable at 
pH 4.5 than at pH 7.2. However, the stability of the abrin-II A-subunit is not affected by a 
change in pH. These observations may assist in an understanding of the physiologically relevant 
transmembrane translocation fthe toxin. 
Keywords: ribosome-inactivating protein, abrin-II, pH, stability, unfolding, guanidine 
hydrochloride, fluorescence, circular dichroism, 8,1-anilino naphthalene sulfonic acid, lactose. 
Introduction 
Ribosome-inactivating protein (RIP) toxins from plants are classified into two groups: Type I 
RIPs are single subunit proteins, e.g., saporin, gelonin, momordin. Type II RIPs are 
heterodimeric proteins, e.g., abrin, ricin, mistletoe lectin (I). The two subunits of type II RIPs 
are designated A- and B- subunits which are connected by a single disulfide bond (2). Type I 
RIPs and the A-subunit of type-II RIPs are N-glycosidases and are potent inhibitors of protein 
biosynthesis acting by the cleavage of the adenine 4324 residue from the 28S rRNA of cell free 
systems i.e., rabbit reticulocyte lysate (3). Type II RIPs are highly cytotoxic. They bind to cell 
surface receptors containing terminal galactose via its B-subunit (4) which facilitates the entry 
of the toxin into the cytosol (5). Both type I and type II RIPs have been used for the 
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preparation of immunotoxins with potential uses in therapy against cancer and infectious 
diseases including AIDS (6). RIPs which in their native state are soluble globular proteins. But 
in order to reach their target hey have to translocate across the membrane of an intracellular 
organelle. It is shown that the toxin enters the cell through receptor-mediated endocytosis (7), 
and that the cleavage of the disulfide bond connecting the A- and B- subunits is necessary for 
the toxin to exercise its action (8). Earlier it was thought that the late endosomes (9) and golgi 
(10) were probable sites for transmembrane transfer of toxin. Recently it was suggested that the 
endoplasmic reticulum is a probable site (11) for the transfer. However, the mechanism 
underlying the transmembrane transport by RIPs is not understood. 
Unlike the case of RIPs from plants, the process of cell intoxication by diphtheria toxin (DT) is 
well understood. Low pH encountered in the endosomes induces conformational change in DT 
resulting in the transport of the A-subunit o the cytosol through the endosomal membrane (12). 
In vitro, DT undergoes a partial unfolding at low pH and this state is capable of translocation. 
Thus from studies on DT it was made clear that transient association of RIPs with the 
membrane is essential for translocation (13). Type-II RIPs are simple proteins which can serve 
as a model system to investigate the molecular mechanism of transmembrane translocation of
cellular proteins. The unravelled mechanism will also assist in the design of therapeutically 
useful immunotoxins. In this study, detailed unfolding studies were carried out on abrin-II. The 
effects of pH on the unfolding pathway and stability of abrin-II after addition of the denaturant, 
guanidine hydrochloride, GdnHCI were investigated by employing fluorescence and circular 
dichroism, CD spectroscopic techniques. 
Materials and methods 
Materials: Abrin-II was purified from seeds ofAbrus precatorius as described in (14). The A- 
subunit of abrin-II was purified using known procedures (15). The concentrations of abrin-II 
and its A-subunit were determined using extinction coefficients of 100170 M'Icm "~ and 23610 
Mlcm ~ at 280 run respectively. All column materials were obtained from Pharmacia (Uppsala, 
Sweden). Ammonium salt of 8,1-anilino naphthalene sulfonic acid (ANS), Guanidine 
hydrochloride (GdnHCI) and lactose were obtained from Sigma Chemicals Co., (St. Louis, MO) 
USA. The concentration f ANS was determined using an extinction of 4.91 x 103 M'lcm ~ at 
363 nm. The concentration f GdnI-IC1 was determined by the refractive index method (16). All 
other chemicals used were of analytical grade and obtained locally. 
Denaturation / renaturation of protein: Denaturation of abrin-II and its A-subunit was 
monitored by measuring changes in fluorescence and circular dichroism, CD spectra. The 
protein was denatured in various concentrations of GdnHC1 either in 50 mM sodium phosphate 
buffer (pH 7.2) or 50 mM sodium acetate buffer (pH 4.5). The protein-GdnHCl mixtures were 
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incubated overnight o achieve equilibrium denaturation at 25 ~ The apparent fraction of 
unfolded protein, F~pp was calculated according to the equation(I) 
F,r~ = (Yob, - V,)/(Yu - Y,) (1) 
where Yob, is the observed value of fluorescence/CD signal at any given denaturant 
concentration and Y, and Y, are the values of Y characteristic of native and unfolded forms of 
protein, respectively. 
For renaturation experiments, tock solutions of denatured protein were diluted to the working 
concentration of the protein in buffer containing the indicated final concentration of GdnHCI. 
The mixtures were incubated overnight to achieve equilibrium renaturation at 25 ~ C. All the 
spectroscopic measurements were made at 25 ~ C. All the baseline corrections were made by 
subtracting the buffer spectrum from the sample spectrum. 
Protein fluorescence: All fluorescence measurements were carried out using a Shimadzu RF- 
5000 Spectrofluorimeter. Intrinsic protein fluorescence spectra were recorded by setting the 
excitation wavelength at 280 nm and the emission was scanned between 300 and 400 nm The 
slitwidths were 3 nm and 5 nm for excitation and emission respectively. 
ANSfluorescence: The fluorescence spectra of ANS were collected on excitation at 420 nm 
with slitwidth of 5 nm and emission spectra were recorded between 440 nm and 530 nm with a 
slitwidth of 5 nm 
Circular dichroism(CD): CD spectra were recorded using a Jasco J-720 spectropolarimeter. 
Secondary structure was monitored by measuring ellipticity at 222 nm using a cell path length 
of 1 mm and tertiary structure was monitored in the wave length range 250-320 nm using a cell 
of path length 5 mm. 
Results 
Denaturation by Guanidine hydrochloride: Protein fluorescence and far UV-and near UV-CD 
were used to monitor changes in secondary and tertiary structure of the protein. The unfolding 
of the abrin-II induced by GdnHCI was assessed by monitoring the change in fluorescence at 
330 nm and by following its far UV-CD at 222 nm. The apparent fraction of unfolded protein, 
Far~ was calculated using equation (1). Fapp was plotted against GdnHCI concentration i  figure 
1. At pH 7.2, the fluorescence-unfolding curve indicates the presence of two transitions caused 
by the increase in GdnHCI concentration. The midpoints of the two transitions were 1.4 M and 
2.8 M GdnHC1. The midpoint of the far UV-CD curve was 2.8 M GdnHC1 at pH 7.2. The 
midpoints of the fluorescence and far UV-CD curves were 2.5 M and 2.9 M GdnHCI, 
respectively at pH 4.5. Non-superimposable fluorescence and far-UV CD suggest he possible 
presence of intermediate states in the unfolding pathway at both pH 7.2 and 4.5. Abrin-II and 
its A-subunit completely unfold in 5 M GdnHCI at both pH 7.2 and 4.5. 
ANSfluorescence: The unfolding exposes hydrophobic patches of the protein to the bulk water. 
This may result in excess binding of extrinsic hydrophobic probes like ANS to the protein (17). 
Figure 2 shows the binding of ANS to abrin-II and its A-subunit as a function of GdnHCI 
417 
Vol. 46, No. 2, 1998 BIOCHEMISTRY and MOLECULAR BIOLOGY INTERNATIONAL 
1.0 
0.8 
~0.6 
m. 
0.4 
0.2 
0.0 
1.0 
0.8 
~.0 .6  
e~ 
0.4 
0.2 
0 0 
a 
b 
0 000  ~ 
/ 
0 1 2 3 4 5 
[G dnH C l] (M)  
Figure 1: GdnHCI induced unfolding transition of Abrin-II. Unfolding was followed using 
fluorescence intensity at 330 nm (4-) and for UV-CD (-o-) at 222 nm. Protein concentrations 
were 0.5 ~M and 3.7 ~ for fluorescence and CD, respectively a) pH 7.2 b) pH 4.5. 
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Figure 2: ANS binding as function of GdnHCl concentration, abrin-II pH 7.2 (4-), abrin-II pH 
4.5 (-o-), and abrin-II A-subunit pH 7.2 ( - ' - ) .  ANS concentration was 100 gM. Protein 
concentration was 2.9 laM for abrin-II and its A-subunit. 
concentrations. For abrin-II two peaks were observed for bound-ANS fluorescence at pH 7.2 
while a single peak was observed for both abrin-II at pH 4.5 and the A-subunit at pH 7.2. 
Figure 3 shows the near-UV CD spectra of abrin-II in the absence and presence of 1.4 M 
GdnHCI at pH 7.2 and 2.2 M GdnHCI at pH 4.5. The changes in the relative fluorescence of
abrin-II in the presence of lactose and the abrin-II A-subunit with increasing the concentration 
of GdnHCI alongwith refolded abrin-II A-subunit are shown in figure 4. The midpoints of the 
curves were 2.1 M and 2.7 M GdnI-ICl at pH 7.2 for abrin-II in presence of lactose and abrin-II 
A-subunit, respectively. The corresponding values of these at pH 4.5 are 2.55 M, 2.7 M. 
Discussion 
The non-coincidence of the unfolding curves shown in fig. 1 suggests the presence of 
intermediates along the unfolding pathways of the abrin-II at both pH 7.2 and 4.5. This 
suggestion is supported by results of the ANS binding (fig. 2) and the near UV-CD (fig. 3) 
studies. The transition midpoints at 1.4 M and 2.8 M GdnHCI obtained from the fluorescence- 
unfolding curve of abrin-II at pH 7.2 (fig. 1) match well with the two maxima in the ANS 
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Figure 3: Dependence ofmean residue llipticity on wavelength in the near UV-CD region of 
abrin-II in presence of 0 M(--), 1.4 M(- -) at a) pH 7.2 and 0 M(--), 2.2 M(- -) at b) pH 
4.5 GdnI-IC1. Protein concentration was 35 IxM. 
binding curve (fig. 2). At 1.4 M GdnHCI, the loss of tertiary structure (fig. 3) without change in 
secondary structure and ANS peak maximum indicate the presence of an intermediate. The 
transition midpoint at 2.8 M GdnI-IC1 in the fluorescence unfolding curve of abrin-II matches 
with the second peak maximum of the ANS binding curve indicating another intermediate at pH 
7.2. It also matches with the peak maximum of ANS binding curve and the midpoint of the 
isolated abrin-II A-subunit at pH 7.2. Therefore, the second transition in fig. 1 for the intact 
toxin may be attributed to the A-subunit. Abrin-II binds to carbohydrates such as lactose and 
galactose via the B-subunit. At pH 7.2, abrin-II in presence of lactose starts unfolding at 1.8 M 
of GdnHCI which is higher than that at 1.2 M in absence of lactose. At pH 4.5, the 
corresponding concentrations of GdnHC1 are 2.0 M and 1.7 M, respectively. The first transition 
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Figure 4: Relative fluorescence (F/F0) as a function of GdnHCl. A) pH 7.2 b) pH 4.5 abrin-II 
+ 50 mM lactose (-*-), its A-subunit (-o-) and refolded abrin-II A-subunit(-"-). Protein 
concentration was 0.5 ~ for abrin-II in presence of lactose, its A-subunit and refolded abrin-II 
A-subunit. 
421 
Vol. 46, No. 2, 1998 BIOCHEMISTRYond MOLECULAR BIOLOGY INTERNATIONAL 
(a) pH 7.2 
OM 
N 
v 
1,4M 
I1 
2.8M 5M 
I2 U 
(b) pH 4.5 
OM 2.2M 5M 
N I U 
Figure 5: Schematic representation fabrin-II unfolding pathway, a) pH 7.2 b) 4.5 
native protein (N), intermediates (Ii, 12, I), unfolded protein (U). 
midpoint ofabrin-II at 1.4 M shifts to 2 M in the presence of lactose. There was no significant 
change in the midpoint of transition of abrin-II A-subunit in presence of lactose at both pH 7.2 
and 4.5. This agrees well with the absence of binding sites for lactose in the A-subunit (18). 
Thus the first transition i  fig. 1 may be due to the galactose binding B-subunit of intact abrin- 
II. The B-subunit is insoluble in aqueous olutions when separated from A-subunit. These 
results at pH 7.2, show that the B-subunit unfolds earlier than A-subunit in intact abrin-II, 
suggesting there is little interaction between the subunits. There were also two-intermediates 
along the unfolding pathway of intact abrin-II. At pH 4.5, non-coincidence of the fluorescence 
and far UV-CD unfolding curves, the presence of a single peak in ANS binding and reduced 
tertiary structure at 2.2 M GdnHCI, suggest the presence of an intermediary form along the 
unfolding path of the abrin-II. At pH 7.2 the onset of unfolding is at 1.2 M GdnHCI whereas it 
shifts to higher concentration f GdnHCI (1.7 M) at pH 4.5. This implies that the intact protein 
is more stable at the acidic pH. Such an increase in stability was also observed in ricin, mistletoe 
lectin and their A-subunits whereas their B-subunits exhibited show a decreased stability at low 
pH (19, 20). In contrast, there was no such effect on the A-subunit of abrin-II. Moreover, 
saporin, gelonin and abrin-II A-subunit (table 1) are more stable than the A-subunits of ricin 
and mistletoe lectin (21, 22). The midpoints of GdnHCI unfolding curves of these proteins are 
shown in table 1. The B-subunits of ricin, and mistletoe lectin undergo structural transitions at 
low pH (23). The GdnHCI induced unfolding pathway of ricin B-subunit occurs through a 
transition intermediate (24). 
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Table 1:GdnHC1 concentrations correspondin~ to the midpoint of the unfoldin 8 transition: 
Protein [GdnHCI], M 
labrin-II 
+50 mM lactose 
A-subunit 
/ricin 
+50 mM lactose 
A-subunit 
B-subunit 
+50 mM lactose 
neutral pH 
Fluorescence 
1.4, 2.8(7.2) 
2.1,2.8(7.2) 
2.7(7.2) 
4.1(7.5) 
5.2(7.5) 
1.5(7.5) 
1.3(7.5) 
2.7(7.5) 
CD 
2.8(7.2) 
low pH 
Fluorescence CD 
2.5(4.5) 
2.55(4.5) 
2.7(4.5) 
5.3(5.0) 
5.5(5.0) 
2.0(5.0) 
0.5(5.0) 
0.6(5.0) 
2.9(4.5) 
3mistletoe l ctin 
+50 mM lactose 
A-subunit 
B-subunit 
+50 mM lactose 
4gelonin 
this study 
4.4(7.0) 
5.4(7.0) 
1.7(7.0) 
1.3(7.0) 
2.1(7.0) 
3.0(7.4) 
5.1(5.o) 
5.6(5.0) 
2.1(5.0) 
1.0(5.0) 
2.2(5.0) 
3.5(5o) 
2,3,4 Values are taken from (19), (20) and (22), respectively. 
Figs in brackets are the pH values of the solutions. 
At pH 4.5, the effect of lactose binding on the protein unfolding curve is less pronounced than 
that at pH 7.2. It is either due to weak binding of lactose to the protein and/or decrease in the 
number of binding sites at pH 4.5. The binding constant and binding stiochiometry of ricin to 
galactose at low pH is 1/10 th and 1/4 th, respectively, of those at neutral pH (25). The 
reversibility of Abrin-II and its A-subunit unfolding has been checked by fluorescence hange at 
both pH 7.2 and 4.5. The recovery of fluorescence is over 80% of the initial emission at pH 7.2 
and 60% at pH 4.5(data not shown) for the intact protein. On the other hand, fluorescence is 
fully reversible at both pH values (fig. 4) for the A-subunit. The proposed unfolding pathway of 
abrin-II is shown in figure 5. 
In summary the following three observations are linked to a proposition for transmembrane 
translocation: a) the stabilization i duced by low pH b) weaker binding to lactose at low pH 
and c) intermediates at both pH 7.2 and 4.5. The low pH in the endosomal compartment would 
cause the dissociation of a significant proportion of the toxin from its receptor, allowing the 
recycling of the latter to the cell-surface. The free toxin in the lumen of the endosome, being 
stable, is not only able to resist degradation but is also able to make its way to the trans golgi 
network and the endoplasmic reticulum. The high lumenal pH destabilizes the toxin, facilitating 
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the reduction of inter-subunit disulfide bond. The A-subunit is now ready to enter the cytosol 
through retrotranslocation. Further characterization is necessary to understand the role of the 
intermediates inthe transmembrane translocation of the toxin. 
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